471 - 480 of 4301 Drugs
Thymoglobulin (anti-thymocyte globulin (rabbit) intravenous administration)
Thymoglobulin [anti-thymocyte globulin (rabbit)] is a purified, pasteurized, gamma immune globulin, indicated for the treatment of renal transplant acute rejection in conjunction with concomitant immunosuppression.
Bioclate (antihemophilic factor)
Bioclate (antihemophilic factor [recombinant]) is a glyco-protein used in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes. Bioclate is also indicated in the perioperative management of patients with hemophilia A. Bioclate may be available in generic form.
Koate (antihemophilic factor)
Koate-DVI Antihemophilic Factor (Human) is a naturally occurring protein in the blood used to treat or prevent bleeding episodes in adults and children with hemophilia A. Koate-DVI Antihemophilic Factor is also used to control bleeding related to surgery or dentistry in a person with hemophilia. Koate-DVI Antihemophilic Factor is not for use in people with von Willebrand disease.
Monoclate-P (antihemophilic factor)
Monoclate-P [Antihemophilic Factor (Human), Factor VIII: C Pasteurized, Monoclonal Antibody Purified] is a naturally occurring protein in the blood used to treat or prevent bleeding episodes in adults and children with hemophilia A. Monoclate-P is also used to control bleeding related to surgery or dentistry in a person with hemophilia. Monoclate-P is not for use in people with von Willebrand disease. Monoclate-P is available in generic form.
Refacto (antihemophilic factor)
ReFacto (antihemophilic factor, recombinant) is a protein used to treat or prevent bleeding episodes in adults and children with hemophilia A. ReFacto is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage. ReFacto is not for use in people with von Willebrand disease. ReFacto is available in generic form.
Xyntha (antihemophilic factor)
Xyntha [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free] is a recombinant coagulation factor VIII used to control and prevent bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia). Xyntha does not treat von Willebrand's disease.
Helixate FS (antihemophilic factor (recombinant))
Helixate FS Antihemophilic Factor (Recombinant) is a naturally occurring protein in the blood used to treat or prevent bleeding episodes in adults and children with hemophilia A. Helixate FS Antihemophilic Factor is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage. Helixate FS Antihemophilic Factor is not for use in people with von Willebrand disease.
Kogenate FS (antihemophilic factor (recombinant))
Kogenate FS [Antihemophilic Factor (Recombinant) Formulated with Sucrose] is a naturally occurring protein in the blood that helps blood to clot (coagulation factor) used to treat or prevent bleeding episodes in adults and children with hemophilia A. Kogenate FS is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage. Kogenate FS is not for use in people with von Willebrand disease. Kogenate FS is available in generic form.
Recombinate (antihemophilic factor (recombinant))
Recombinate Antihemophilic Factor (Recombinant) is a naturally occurring protein in the blood that helps blood to clot used to treat or prevent bleeding episodes in adults and children with hemophilia A. Recombinate Antihemophilic Factor is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage. Recombinate Antihemophilic Factor is not for use in people with von Willebrand disease.
Kovaltry (antihemophilic factor (recombinant) for intravenous administration)
Kovaltry [Antihemophilic Factor (Recombinant)] Lyophilized Powder for Solution for Intravenous Injection is a recombinant, human DNA sequence derived, full length Factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital Factor VIII deficiency) for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. Kovaltry is not indicated for the treatment of von Willebrand disease.